MVHealth: Timeline of Main Events

2014

* Company Formation in the UK: MVHealth is established in the United Kingdom.

* Crescendo Prototype: Development of the initial prototype for the Crescendo device.

2015

* End-to-End R&D Centre Setup in UK: MVHealth establishes its own research and development facility in the UK.

* Tenuto Prototype: Development of the initial prototype for the Tenuto device.

* Seed Funding Round: MVHealth raises $1.3m with a pre-money valuation (PMV) of $4.9m.

2016

* Crescendo Launch: The Crescendo device is officially launched.

* Seed Funding Round: MVHealth raises an additional $718k with a PMV of $6.6m.

2017

* Apple iOS App Launch: MVHealth releases its companion application for Apple devices.

* Google Android App Launch: The Android version of the MVHealth application is launched.

* Poco Prototype: Development begins for the Poco device.

* Remote Prototype: Initial development of a remote control device (likely for their products).

* TC Disrupt, Pioneers: MVHealth participates in the TechCrunch Disrupt event.

* Hardware Club: MVHealth joins the Hardware Club, an exclusive community for hardware startups.

* Awards: MVHealth receives Red Dot Design and Virgin Voom Export awards, and is recognized as a Top 100 Startup.

2018

* Poco Launch: The Poco device is officially released.

* Remote Launch: The remote control device is launched.

* Fully-Owned Subsidiary in US: MVHealth establishes a subsidiary in the United States.

* Angels Funding Round: MVHealth secures $1.5m in funding with a PMV of $14.1m.

* FDA Class II Device Registration: MVHealth achieves FDA Class II medical device registration.

* Launched D2C Site: MVHealth begins selling directly to consumers through their own website.

* London Mayor's Programme: MVHealth participates in a program supported by the Mayor of London.

* Crescendo GPPPD & Tenuto ED Studies Published: Clinical studies demonstrating the effectiveness of Crescendo for Genito-Pelvic Pain Disorders (GPPPD) and Tenuto for Erectile Dysfunction (ED) are published.

* Awards: MVHealth receives Management Today, The Drum, Creative Tech, and Clio awards.

2019

* Tenuto 2 & Crescendo 2 Prototypes: Development of the next generation devices, Tenuto 2 and Crescendo 2, begins.

* Angels Funding Round: MVHealth raises a further $2m with a PMV of $18.9m.

* Whitelisted by Meta, Google, Microsoft: MVHealth achieves whitelisting status with major technology platforms.

* Upgraded to Sustainable Packaging: The company transitions to more environmentally friendly packaging.

* Developed Back Pain Belt for PainCareLabs & Compact Massager for Large Corporate: MVHealth leverages its technology to create products for other companies, including a back pain belt using their malleable technology for Pain Care Labs and a compact massager for an unnamed large corporate.

* Awards: MVHealth is recognized by Design Week (beating Apple), Veuve Clicquot, and IF Design Awards.

2020

* Tenuto 2 & Crescendo 2 Launch: The Tenuto 2 and Crescendo 2 devices are officially released.

* 1M+ App Downloads: The MVHealth companion application reaches over one million downloads.

* Awards: MVHealth receives Virgin Startups, Euro Product Design, LUXLife, Disruption50, Great British Entrepreneur, Welp, and The Escape100 awards.

2021

* Tenuto Mini, Legato, Molto Launch: MVHealth significantly expands its product line with the launch of Tenuto Mini, Legato, and Molto devices.

* Series A Funding Round: MVHealth secures $9.6m in Series A funding with a PMV of $36m.

* Awards: MVHealth is recognized as a Top 10 Deeptech company and a Top Product Design Company in the UK.

2022

* FSA/HSA Eligible: MVHealth devices become eligible for Flexible Spending Account (FSA) and Health Savings Account (HSA) spending.

* Crescendo FSAD Study Published: A clinical study demonstrating the effectiveness of Crescendo for Female Sexual Arousal Disorder (FSAD) is published.

* Endorsed by Mayo Clinic: MVHealth receives an endorsement from the Mayo Clinic.

* Member of CHPA & Advamed: MVHealth becomes a member of the Consumer Healthcare Products Association (CHPA) and AdvaMed (Advanced Medical Technology Association).

* Awards: MVHealth receives Dezeen, UX Design, World Future, Muse Design, and Good Design awards.

2023

* Firmo & Sotto Prototypes: Development begins for the Firmo and Sotto devices, targeting menopause symptoms and period pain/mastitis respectively.

* Legato FSAD and Tenuto Mini ED Studies Published: Clinical studies are published supporting the use of Legato for FSAD and Tenuto Mini for ED.

* Awards: MVHealth receives Bold IV, Impact Fifty, Titan, London Design, and DNA Paris Design awards.

2024 (Upcoming)

* Further development and potential launch of Firmo and Sotto devices.

* Continued focus on research, development, and market expansion.

* Pursuing full CMS reimbursement.

Ongoing Throughout the Decade:

* Research, Development & Manufacturing: Continuous efforts in new product development and updates to existing products.

* Regulatory & Compliance Approval: Obtaining necessary approvals such as FDA and CE for their devices.

* Clinical Trials & Paper Publications: Conducting clinical studies and publishing findings in peer-reviewed journals.

* Key Opinion Leader Onboarding & Endorsement: Building relationships with and securing endorsements from leading clinicians.

* User Feedback & Efficacy Establishment: Gathering user feedback and establishing the efficacy of their devices.

* Brand Awareness & Market Presence: Increasing brand recognition and expanding their presence in the market through direct sales, clinics, and hospitals.

* IP Portfolio Development: Continuously expanding their patent and trademark portfolio.

* Brand Credibility Building: Establishing trust through high efficacy, KOL endorsements, and user satisfaction.

* Large-scale Nationwide Marketing & Trade Exhibitions: Engaging in significant marketing efforts and participating in industry events.

* Reimbursement Efforts: Actively working towards securing reimbursement for their devices.

* Building Strategic Partnerships: Collaborating with large corporates and healthcare companies.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.uhaid.org